19/02/2010 (Agence Europe) - On Thursday 18 February, the European Medicines Agency recommended that conditional marketing authorisation be granted for the A(H1N1) pandemic flu vaccine Humenza from Sanofi Pasteur SA. This is the fifth pandemic vaccine recommended for use by the EMEA. (O.J./transl.rt)